#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pleomorphic liposarcoma Indolent systemic mastocytosis Macular telangiectasia Oesophageal adenocarcinoma stage II Erythema multiforme Chronic graft versus host disease in liver Synovitis Hepatobiliary cancer T-cell lymphoma Acute leukaemia Ductal adenocarcinoma of pancreas Lymphangiosarcoma Adult T-cell lymphoma/leukaemia refractory Immune-mediated renal disorder Pelizaeus-Merzbacher disease More trials…

    Learn about Rare Diseases

    Hepatic angiosarcoma – Basic Information Von Willebrand’s disease – Basic Information Mast cell activation syndrome – Diagnostics Crigler-Najjar syndrome Primary mediastinal large B-cell lymphoma – Life with Disease Rosai-Dorfman syndrome – Basic Information Systemic mastocytosis – Diagnostics Hairy cell leukaemia – Diagnostics Leiomyosarcoma metastatic Crigler-Najjar syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    HYDROXYCHLOROQUINE Eight Treg Agrostis Stolonifera Pollen Golcadomide Rimegepant AZD5148 TETANUS TOXOID Fosinopril Sodium Diphenhydramine AVTX-009 Relatlimab Cetirizine Dihydrochloride VINBLASTINE Holcus Lanatus Pollen Extract Danazol Toldc Pitolisant Raludotatug Deruxtecan Apg777 Dabrafenib Mesylate More therapies…

    Learn about Your Condition

    Left ventricular dysfunction Metastases to rectum Vasoplegia syndrome Renal disorder Embolism Tetanus Epilepsy Proteinuria Thalassaemia alpha VEXAS syndrome Respiratory failure Cervix carcinoma Kidney transplant rejection Friedreich's ataxia CDKL5 deficiency disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Durvalumab, Cisplatin, Carboplatin, and Etoposide for Patients with Extensive Stage Small Cell Lung Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    • Small cell lung cancer metastatic
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Durvalumab
    Germany

  • Study on Daratumumab, Carfilzomib, Pomalidomide, and Dexamethasone for Patients with Multiple Myeloma and Acute Kidney Failure

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Carfilzomib
    • Daratumumab
    • Dexamethasone
    Austria

  • A Phase III Study of Elafibranor in Adults with Primary Sclerosing Cholangitis to Assess Efficacy and Safety

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Cholangitis sclerosing
    Investigated Drugs:
    • Elafibranor
    Austria Belgium Czechia Denmark Finland France +9

  • Study on Apremilast for Patients with Severe Recurrent Mouth Ulcers Resistant to Colchicine

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Stomatitis
    Investigated Drugs:
    • Apremilast
    France

  • Safety and Efficacy Study of the Acne mRNA vaccine (mrt1800, mrt1801, mrt1802) in Adults 18‑45 Years with Moderate to Severe Acne

    Not yet recruiting

    2 1
    Germany Poland Spain

  • Study of BIIB115 in patients aged 15‑60 years with spinal muscular atrophy who are treatment‑naïve or previously treated with risdiplam

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • BIIB115
    Finland France Germany Ireland Italy Poland +1
Previous Page
1 … 906 907 908 909 910 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!